Which peptides are studied for brain, nerve and sleep conditions?

Short answer

13 profiles here are grouped under “Brain, nerves and sleep”: 4 FDA-approved, 1 in clinical trials and 8 not FDA-approved.

Each entry below quotes its profile and links to the full answer there.

FDA-approved 4

In clinical trials 1

Not FDA-approved 8

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    Drugs@FDA: COPAXONE (glatiramer acetate), NDA 020622 · original approval December 20, 1996 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  2. 2
    COPAXONE (glatiramer acetate injection) · SPL version 36 · published 2026-06-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  3. 3
    PITOCIN (oxytocin) injection · SPL version 15 · published 2026-05-21 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  4. 4
    Drugs@FDA: PITOCIN (oxytocin), NDA 018261 · original approval November 19, 1980 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  5. 5
    DAYBUE (trofinetide) solution; DAYBUE STIX (trofinetide) for solution · SPL version 12 · published 2026-09-11 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  6. 6
    Drugs@FDA: DAYBUE (trofinetide), NDA 217026 · original approval March 10, 2023 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  7. 7
    PRIALT (ziconotide acetate) injection, solution · SPL version 6 · published 2025-07-14 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  8. 8
    Drugs@FDA application NDA021060 · original submission status AP · 2004-12-28 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  9. 9
    Cibinetide (ARA 290) substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 15, 2026

  10. 10
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  11. 11
    Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain (2017) · PMID 28475703 ↗

    Investigative Ophthalmology & Visual Science · Official source · Source checked November 15, 2026

  12. 12
    Cerebrolysin substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  13. 13
    FDA briefing document for emideltide (DSIP) (free base) and emideltide acetate ↗

    U.S. Food and Drug Administration · Official source · Source checked July 29, 2026

  14. 14
    FDA briefing document for epitalon ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  15. 15
    Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances · notice of availability · 91 FR 68526 · October 30, 2026 ↗

    Federal Register · U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026

  16. 16
    HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, with Appendix A (list of peptides) and Appendix B (identities and justifications) ↗

    U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026

  17. 17
    Humanin substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  18. 18
    FDA briefing document for Semax ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  19. 19
    Tesofensine substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026